FDA Inspection 1114962 — American Red Cross Blood Services

American Red Cross Blood Services — FEI 1276529

The FDA completed an inspection of American Red Cross Blood Services on Jan 7, 2020 in Springfield, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jan 7, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Springfield, MA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.